Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
750 participants
INTERVENTIONAL
2019-01-17
2023-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accelerated Treatment of Endocarditis
NCT05144399
Beta-lactam Pharmacokinetics in Patients With Infective Endocarditis
NCT02033421
Betalactam Pharmacokinetics in Endocarditis Patients
NCT04647331
Hyperbaric Oxygen Treatment in Humans With Gram Positive Cocci Endocarditis
NCT04691440
Antibiotic Resistance in Danish EDs.
NCT03352167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
Usual guideline therapy
Usual guideline therapy
Usual guideline therapy
Accelerated arm
Accelerated treatment of endocarditis
Accelerated treatment of endocarditis
For the three main bacteria species we shorten the duration of antibiotic treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accelerated treatment of endocarditis
For the three main bacteria species we shorten the duration of antibiotic treatment
Usual guideline therapy
Usual guideline therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The patient may be included \<14 days after beginning of relevant antibiotic treatment.
3. Left-sided endocarditis with one of the following microorganisms: Streptococci; Enterococcus faecalis; Staphylococcus aureus.
4. Patients ≥ 18 years.
Exclusion Criteria
2. Incapability to give informed consent for participation.
3. Relapse Endocarditis (Endocarditis with the same bacteria within six months).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Nordsjaellands Hospital
OTHER
Zealand University Hospital
OTHER
Odense University Hospital
OTHER
Aarhus University Hospital
OTHER
Lund University Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kasper Iversen
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henning Bundgaard, MD
Role: STUDY_CHAIR
Rigshospitalet, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Skejby Sygehus
Aarhus, , Denmark
Rigshospitalet
Copenhagen, , Denmark
Gentofte Hospital
Copenhagen, , Denmark
Herlev Hoslpital
Copenhagen, , Denmark
Hillerød Hospital
Hillerød, , Denmark
Odense Sygehus
Odense, , Denmark
Roskilde Sygehus
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Henning Bundgaard
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-18028566
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.